Biomarkers are still largely unknown by cancer patients and are insufficiently used by physicians.

The latter use diagnostic tests to clarify and support their clinical decision making and poor patient knowledge, difficulties in reimbursement and lack of existing biomarkers in some European countries are an obstacle to improving cancer patients’ clinical outcomes.

Here we will discuss:

• What are Biomarkers?
• Information to Patient
• Recommendations for Policy Maker
• What can be Done?

• Increase Biomarker Literacy.
• Improve Access.
• Adapting the Regulatory Framework.